DetectnetActive Ingredient(s): Copper Dotatate Cu-64
FDA Approved: * September 3, 2020
Pharm Company: * RADIOMEDIX
Category: Diagnostic Aid
Copper (64Cu) oxodotreotide or Copper Cu 64 dotatate, sold under the brand name Detectnet, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adults. Common side effects include nausea, vomiting and flushing. It was approved for medical use in the United States in September 2020. Contents 1 His... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.